Surgical therapy of hepatocellular carcinoma in the cirrhotic liver

S T Fan1

  • 1Centre of Liver Diseases, University of Hong Kong, Queen Mary Hospital, China.

Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera
|July 22, 1999
PubMed

Insights

Hepatectomy for liver cancer in cirrhotic patients is now safer. Improved surgical techniques and perioperative care significantly reduced hospital mortality and improved survival rates for hepatocellular carcinoma patients with cirrhosis.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hepatectomy for hepatocellular carcinoma (HCC) in cirrhotic patients historically carried high mortality rates.
  • This led to the perception of contraindication for major hepatectomy in this patient group.

Purpose of the Study:

  • To report a refined surgical approach for hepatectomy in cirrhotic patients with HCC.
  • To evaluate the impact of this approach on perioperative mortality and long-term survival.

Main Methods:

  • A retrospective analysis of 98 cirrhotic patients undergoing hepatectomy (66 major, 32 minor) between 1989 and 1995.
  • Patient selection based on indocyanine green clearance tests.
  • Surgical techniques focused on minimizing blood loss, ischemic injury, and preserving liver parenchyma.
  • Postoperative care aimed at maintaining or improving liver function.

Main Results:

  • Hospital mortality for cirrhotic patients undergoing hepatectomy decreased from 40% in 1989 to 5% in 1995.
  • The 5-year survival rate improved to 41.2%, comparable to patients with normal or chronically diseased livers.

Conclusions:

  • Refined surgical techniques and perioperative management have made hepatectomy a viable and beneficial option for cirrhotic patients with HCC.
  • This approach significantly improves outcomes, challenging previous contraindications.